AU3585397A - Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications - Google Patents

Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications

Info

Publication number
AU3585397A
AU3585397A AU35853/97A AU3585397A AU3585397A AU 3585397 A AU3585397 A AU 3585397A AU 35853/97 A AU35853/97 A AU 35853/97A AU 3585397 A AU3585397 A AU 3585397A AU 3585397 A AU3585397 A AU 3585397A
Authority
AU
Australia
Prior art keywords
domain
pharmaceutical
particles
useful
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35853/97A
Other languages
English (en)
Inventor
Haiyong Huang
K. Bruce II Thurmond
James M. Warner
Karen L. Wooley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of AU3585397A publication Critical patent/AU3585397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Steroid Compounds (AREA)
AU35853/97A 1996-06-27 1997-06-27 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications Abandoned AU3585397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2069396P 1996-06-27 1996-06-27
US60020693 1996-06-27
PCT/US1997/011345 WO1997049387A1 (en) 1996-06-27 1997-06-27 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications

Publications (1)

Publication Number Publication Date
AU3585397A true AU3585397A (en) 1998-01-14

Family

ID=21800036

Family Applications (2)

Application Number Title Priority Date Filing Date
AU35853/97A Abandoned AU3585397A (en) 1996-06-27 1997-06-27 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
AU36496/97A Abandoned AU3649697A (en) 1996-06-27 1997-06-27 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU36496/97A Abandoned AU3649697A (en) 1996-06-27 1997-06-27 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications

Country Status (6)

Country Link
US (2) US6491903B1 (US06491903-20021210-C00024.png)
EP (2) EP0910351A1 (US06491903-20021210-C00024.png)
JP (2) JP2000514791A (US06491903-20021210-C00024.png)
AU (2) AU3585397A (US06491903-20021210-C00024.png)
CA (2) CA2258851A1 (US06491903-20021210-C00024.png)
WO (2) WO1997049387A1 (US06491903-20021210-C00024.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011703A1 (en) * 1997-08-29 1999-03-11 Biotech Australia Pty. Limited Cross-linked particles

Families Citing this family (223)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
AU3585397A (en) * 1996-06-27 1998-01-14 G.D. Searle & Co. Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
US6479145B1 (en) * 1999-09-09 2002-11-12 Regents Of The University Of Minnesota Biopolymers and biopolymer blends, and method for producing same
US6916488B1 (en) * 1999-11-05 2005-07-12 Biocure, Inc. Amphiphilic polymeric vesicles
EP1231905B1 (en) 1999-11-15 2009-04-08 BioCure, Inc. Responsive polymeric hollow particles
EP1267946A4 (en) * 2000-02-28 2008-07-02 Genesegues Inc SYSTEM AND METHOD FOR ENCAPSULATING NANOCAPSULES
AUPQ679400A0 (en) * 2000-04-07 2000-05-11 Commonwealth Scientific And Industrial Research Organisation Microgel synthesis
US7064151B1 (en) 2000-04-07 2006-06-20 E. I. Du Pont De Nemours And Company Process of microgel synthesis and products produced therefrom
DE60119318T2 (de) * 2000-05-29 2007-05-03 Bio Merieux Biokompatible polymere für die bindung von biologischen liganden
US7897404B2 (en) * 2000-09-29 2011-03-01 Roche Diagnostics Operations, Inc. Conjugates of defined stoichiometry
AU2002214583A1 (en) * 2000-10-11 2002-04-22 Purdue Research Foundation Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof
US20050158271A1 (en) * 2000-10-11 2005-07-21 Lee Sang C. Pharmaceutical applications of hydrotropic polymer micelles
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
FR2824563B1 (fr) * 2001-05-10 2004-12-03 Bio Merieux Particules composites, conjugues derives, procede de preparation et applications
US6780428B2 (en) * 2001-06-08 2004-08-24 Labopharm, Inc. Unimolecular polymeric micelles with an ionizable inner core
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US7094810B2 (en) * 2001-06-08 2006-08-22 Labopharm, Inc. pH-sensitive block copolymers for pharmaceutical compositions
KR100566911B1 (ko) * 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
US8815793B2 (en) 2001-07-20 2014-08-26 Northwestern University Polymeric compositions and related methods of use
US7858679B2 (en) 2001-07-20 2010-12-28 Northwestern University Polymeric compositions and related methods of use
US7618937B2 (en) 2001-07-20 2009-11-17 Northwestern University Peptidomimetic polymers for antifouling surfaces
US6916536B1 (en) * 2001-09-20 2005-07-12 Christopher R. Hammen Composites incorporating covalently bonded interstitial polymer resins
US6956084B2 (en) 2001-10-04 2005-10-18 Bridgestone Corporation Nano-particle preparation and applications
JP4094277B2 (ja) * 2001-11-09 2008-06-04 独立行政法人科学技術振興機構 シェル架橋型ミセルを鋳型とする金属ナノ粒子の調製
CA2470524A1 (en) * 2001-12-21 2003-07-24 David S. Soane Use of oligomers and polymers for drug solublization, stabilization, and delivery
CN1200030C (zh) * 2002-02-05 2005-05-04 复旦大学 一步法制备结构稳定、高浓度且具有核－壳结构的聚合物纳米胶束
JP4091917B2 (ja) * 2002-03-20 2008-05-28 ローディア，インコーポレイテッド 両親媒性ジブロック共重合体及び疎水性化合物を含むベシクル
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
WO2003090255A2 (en) * 2002-04-18 2003-10-30 Northwestern University Encapsulation of nanotubes via self-assembled nanostructures
WO2003104307A1 (en) * 2002-06-10 2003-12-18 Rhodia Inc Phase-separated composition comprising two miscible solvents, and use thereof in a process for making capsules
DE60307371T2 (de) * 2002-06-14 2007-08-02 Canon K.K. Partikelzusammensetzung, Aufzeichnungsverfahren sowie Aufzeichnungsgerät unter Verwendung der Partikelzusammensetzung
JP3890266B2 (ja) * 2002-07-03 2007-03-07 キヤノン株式会社 ブロックポリマー化合物、インク組成物、分散性組成物及び画像形成方法並びに画像形成装置
US20080226723A1 (en) * 2002-07-05 2008-09-18 Celonova Biosciences, Inc. Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same
US7160551B2 (en) * 2002-07-09 2007-01-09 The Board Of Trustees Of The University Of Illinois Injectable system for controlled drug delivery
US8911831B2 (en) 2002-07-19 2014-12-16 Northwestern University Surface independent, surface-modifying, multifunctional coatings and applications thereof
US20040016702A1 (en) * 2002-07-26 2004-01-29 Applera Corporation Device and method for purification of nucleic acids
US7465463B2 (en) * 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
US7387832B2 (en) 2002-09-19 2008-06-17 Nisshinbo Industries, Inc. Flat particles and process for production thereof
US7045069B2 (en) * 2002-11-14 2006-05-16 Gennady Ozeryansky Microfabrication method based on metal matrix composite technology
FR2848452B1 (fr) * 2002-12-12 2007-04-06 Aventis Pharma Sa Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
DE10258007B4 (de) 2002-12-12 2006-02-09 Sanofi-Aventis Deutschland Gmbh Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
AU2003301053A1 (en) * 2002-12-18 2004-07-22 Bridgestone Corporation Method for clay exfoliation, compositions therefore, and modified rubber contaiing same
US6858301B2 (en) * 2003-01-02 2005-02-22 Hewlett-Packard Development Company, L.P. Specific core-shell polymer additive for ink-jet inks to improve durability
CA2523413A1 (en) * 2003-04-25 2004-11-11 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US7332527B2 (en) * 2003-05-16 2008-02-19 Board Of Regents Of The University Of Nebraska Cross-linked ionic core micelles
US7317521B2 (en) * 2003-09-18 2008-01-08 Micron Technology, Inc. Particle detection method
US7311901B2 (en) * 2003-10-10 2007-12-25 Samyang Corporation Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
US7214825B2 (en) * 2003-10-17 2007-05-08 Honeywell International Inc. O-(3-chloropropenyl) hydroxylamine free base
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US8309112B2 (en) * 2003-12-24 2012-11-13 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
US7205370B2 (en) * 2004-01-12 2007-04-17 Bridgestone Corporation Polymeric nano-particles of flower-like structure and applications
EP1559790A1 (de) * 2004-02-02 2005-08-03 International University Bremen Gmbh Vesikel zum Abtrennen von Substanzen aus flüssigen Medien
US20050181000A1 (en) * 2004-02-17 2005-08-18 Lundquist Eric G. Polymeric nanoparticles in consumer products
US8063142B2 (en) * 2004-03-02 2011-11-22 Bridgestone Corporation Method of making nano-particles of selected size distribution
US7718737B2 (en) * 2004-03-02 2010-05-18 Bridgestone Corporation Rubber composition containing functionalized polymer nanoparticles
US8282960B2 (en) 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
WO2005095950A1 (en) * 2004-03-30 2005-10-13 Pfizer Products Inc. Method and device for evaluation of pharmaceutical compositions
US7556799B2 (en) 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US8192758B2 (en) 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US7429394B2 (en) 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
EP3574896A1 (en) * 2004-03-30 2019-12-04 Relypsa, Inc. Ion binding polymers and uses thereof
US7854924B2 (en) * 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
KR101228233B1 (ko) 2004-03-30 2013-01-31 리립사, 인크. 이온 결합 중합체 및 이의 용도
US20050228074A1 (en) * 2004-04-05 2005-10-13 Bridgestone Corporation Amphiphilic polymer micelles and use thereof
US20050226932A1 (en) * 2004-04-09 2005-10-13 Samyang Corporation Pharmaceutical formulations for itraconazole
US7507439B2 (en) * 2004-05-06 2009-03-24 Hewlett-Packard Development Company, L.P. Use and preparation of crosslinked polymer particles for inkjet recording materials
US20050282956A1 (en) 2004-06-21 2005-12-22 Xiaorong Wang Reversible polymer/metal nano-composites and method for manufacturing same
WO2006085962A2 (en) * 2004-06-30 2006-08-17 Massachusetts Intstitute Of Technology Photogenerated polyelectrolyte bilayers from an aqueous-processible photoresist
US7998554B2 (en) 2004-07-06 2011-08-16 Bridgestone Corporation Hydrophobic surfaces with nanoparticles
EP1781257B1 (en) * 2004-08-13 2018-12-19 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
MX2007002783A (es) * 2004-09-09 2009-02-12 Bayer Animal Health Gmbh Composición farmacéutica.
US9011831B2 (en) 2004-09-30 2015-04-21 Advanced Cardiovascular Systems, Inc. Methacrylate copolymers for medical devices
AU2005294214A1 (en) * 2004-10-07 2006-04-20 Emory University Multifunctional nanoparticles conjugates and their use
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US8354093B2 (en) 2004-10-15 2013-01-15 Washington University Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
KR101153785B1 (ko) 2004-10-25 2012-07-09 셀로노바 바이오사이언시스 저머니 게엠베하 치료 및/또는 진단용으로 부가할 수 있는 중합체 입자 및이의 제조 및 사용 방법
US9107850B2 (en) * 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20060091228A1 (en) * 2004-11-02 2006-05-04 Keh-Ying Hsu Moisture-absorbing polymer particle, method for forming the same and application thereof
US20080032238A1 (en) * 2004-11-23 2008-02-07 Lu Jennifer Q System and method for controlling the size and/or distribution of catalyst nanoparticles for nanostructure growth
US7364672B2 (en) 2004-12-06 2008-04-29 Arlon, Inc. Low loss prepregs, compositions useful for the preparation thereof and uses therefor
US20110177306A1 (en) * 2004-12-17 2011-07-21 Mitsubishi Chemical Corporation Novel Core-Shell Structure
US7572855B2 (en) * 2005-01-28 2009-08-11 Bridgestone Corporation Nano-composite and compositions manufactured thereof
US7579398B2 (en) * 2005-02-02 2009-08-25 Bridgestone Corporation Nano-composite and compositions therefrom
US7659342B2 (en) 2005-02-03 2010-02-09 Bridgestone Corporation Polymer nano-particle with polar core and method for manufacturing same
GB0505569D0 (en) * 2005-03-18 2005-04-27 Syngenta Ltd Formulations
US20060224095A1 (en) * 2005-04-05 2006-10-05 University Of New Hampshire Biocompatible polymeric vesicles self assembled from triblock copolymers
WO2006119960A1 (en) * 2005-05-06 2006-11-16 Unilever Plc Cosmetic composition comprising a micellar, shell cross-linked copolymer
KR101259853B1 (ko) * 2005-08-01 2013-05-02 주식회사 동진쎄미켐 감광성 고분자 및 이를 포함하는 포토레지스트 조성물
WO2007024501A2 (en) * 2005-08-25 2007-03-01 Medtronic Vascular, Inc. Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore
US20090220607A1 (en) * 2005-09-15 2009-09-03 Kiser Patrick F Polymeric compositions and methods of making and using thereof
AU2006294455B2 (en) 2005-09-30 2013-06-20 Relypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
DE112006002618T5 (de) 2005-09-30 2008-08-28 Ilypsa Inc., Santa Clara Verfahren und Zusammensetzungen zum selektiven Entfernen von Kaliumionen aus dem Gastrointestinaltrakt eines Säugers
US9061900B2 (en) * 2005-12-16 2015-06-23 Bridgestone Corporation Combined use of liquid polymer and polymeric nanoparticles for rubber applications
US7538159B2 (en) * 2005-12-16 2009-05-26 Bridgestone Corporation Nanoparticles with controlled architecture and method thereof
US7884160B2 (en) 2005-12-19 2011-02-08 Bridgestone Corporation Non-spherical nanoparticles made from living triblock polymer chains
US8288473B2 (en) 2005-12-19 2012-10-16 Bridgestone Corporation Disk-like nanoparticles
US7601772B2 (en) * 2005-12-20 2009-10-13 Bridgestone Corporation Nano-composite and method thereof
US8697775B2 (en) * 2005-12-20 2014-04-15 Bridgestone Corporation Vulcanizable nanoparticles having a core with a high glass transition temperature
US8877250B2 (en) * 2005-12-20 2014-11-04 Bridgestone Corporation Hollow nano-particles and method thereof
US7732539B2 (en) 2006-02-16 2010-06-08 National Science Foundation Modified acrylic block copolymers for hydrogels and pressure sensitive wet adhesives
US7863381B2 (en) * 2006-03-08 2011-01-04 3M Innovative Properties Company Polymer composites
US7829140B1 (en) 2006-03-29 2010-11-09 The Research Foundation Of The State University Of New York Method of forming iron oxide core metal shell nanoparticles
CA2649915A1 (en) * 2006-04-20 2007-11-01 University Of Utah Research Foundation Polymeric compositions and methods of making and using thereof
US8703167B2 (en) * 2006-06-05 2014-04-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
US20080009211A1 (en) * 2006-07-07 2008-01-10 Matthew Raymond Himes Assemblies useful for the preparation of electronic components and methods for making same
JP6096398B2 (ja) 2006-07-28 2017-03-15 株式会社ブリヂストン 重合体ナノ粒子、ゴム組成物及び使用
JP5597836B2 (ja) 2006-08-04 2014-10-01 ケンジー ナッシュ コーポレイション バイオミメティック化合物およびその合成方法
WO2008091386A2 (en) 2006-08-04 2008-07-31 Northwestern University Biomimetic modular adhesive complex: material, methods and applications therefore
US8124598B2 (en) 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
BRPI0716890A2 (pt) * 2006-09-22 2013-10-22 Labopharm Inc Composição, e, método de produção de uma composição, de administração de um agente farmaceuticamente ativo insolúvel em água a um mamífero, e de tratamento de câncer em um mamífero
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
EP2089411A4 (en) 2006-12-04 2010-01-27 Univ Illinois COMPOSITIONS AND METHODS FOR CANCER TREATMENT WITH CUPREDOXINES AND CPG-RICH DNA
US7597959B2 (en) * 2006-12-19 2009-10-06 Bridgestone Corporation Core-shell fluorescent nanoparticles
US7649049B2 (en) 2006-12-20 2010-01-19 Bridgestone Corporation Rubber composition containing a polymer nanoparticle
WO2008091546A1 (en) * 2007-01-22 2008-07-31 Seashell Technology Llc. Composite and layered particles for efficient delivery of polyelectrolytes
WO2008098216A2 (en) 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
US8383092B2 (en) * 2007-02-16 2013-02-26 Knc Ner Acquisition Sub, Inc. Bioadhesive constructs
US8673286B2 (en) 2007-04-09 2014-03-18 Northwestern University DOPA-functionalized, branched, poly(aklylene oxide) adhesives
US8343627B2 (en) 2007-02-20 2013-01-01 Research Foundation Of State University Of New York Core-shell nanoparticles with multiple cores and a method for fabricating them
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
US8703204B2 (en) * 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135852A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Pharmaceutical compositions comprising nanoparticles and casein
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2008149192A2 (en) * 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US7829624B2 (en) 2007-06-29 2010-11-09 Bridgestone Corporation One-pot synthesis of nanoparticles and liquid polymer for rubber applications
WO2009010842A2 (en) * 2007-07-13 2009-01-22 Pfizer Products Inc. Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009012162A2 (en) * 2007-07-16 2009-01-22 Allvivo Vascular, Inc. Antimicrobial constructs
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
EP2042538A1 (en) * 2007-09-18 2009-04-01 Nirvana's Tree House Amphiphilic copolymers and compositions containing such polymers
EP2209420A4 (en) 2007-10-09 2014-01-22 Univ St Louis IMAGING PARTICLES
KR20100087158A (ko) * 2007-10-09 2010-08-03 크레이튼 폴리머즈 유.에스. 엘엘씨 특정 블록 공중합체로 제조된 최종 용도 제품
US9468607B2 (en) * 2007-10-09 2016-10-18 Washington University Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
US20090110738A1 (en) * 2007-10-26 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same
US20090111763A1 (en) * 2007-10-26 2009-04-30 Celonova Biosciences, Inc. Loadable polymeric particles for bone augmentation and methods of preparing and using the same
US20090110731A1 (en) * 2007-10-30 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same
WO2009061473A2 (en) * 2007-11-07 2009-05-14 Mallinckrodt Inc. Photonic shell-core cross linked and functionalized nanostructures for biological applications
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US9233078B2 (en) * 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
KR101462536B1 (ko) * 2007-12-17 2014-11-19 삼성디스플레이 주식회사 안료 분산계 및 안료의 캡슐화 방법
WO2009130144A2 (en) * 2008-04-23 2009-10-29 Basf Se Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate
JP5317031B2 (ja) * 2008-05-07 2013-10-16 公立大学法人大阪府立大学 ヘッド−テイル型共重合体の中空ナノ微粒子
JP5755563B2 (ja) * 2008-05-13 2015-07-29 ユニヴァーシティ オブ ワシントン ミセル集合体
US20090291310A1 (en) * 2008-05-22 2009-11-26 Fields Ii Kenneth A Opal latex
WO2010022380A2 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
AU2016200413B2 (en) * 2008-09-25 2017-09-14 Vive Nano, Inc. Methods to produce polymer nanoparticles and formulations of active ingredients
AU2014201945B2 (en) * 2008-09-25 2015-10-29 Vive Nano, Inc. Methods to produce polymer nanoparticles and formulations of active ingredients
EP3378310B1 (en) 2008-09-25 2021-08-04 Vive Crop Protection Inc. Methods to produce polymer nanoparticles and formulations of active ingredients
WO2010047765A2 (en) * 2008-10-20 2010-04-29 Massachussetts Institute Of Technology Nanostructures for drug delivery
US8445601B2 (en) * 2008-11-14 2013-05-21 3M Innovative Properties Company Polymeric compositions and method of making and articles thereof
JP5620405B2 (ja) 2008-12-31 2014-11-05 株式会社ブリヂストン 最初にコアを形成するナノ粒子形成プロセス、ナノ粒子、及び組成物
US8709601B2 (en) * 2009-01-30 2014-04-29 Hewlett-Packard Development Company, L.P. Block copolymer nanoparticle compositions
US20100203150A1 (en) * 2009-02-06 2010-08-12 National Tsing Hua University Novel amphiphilic copolymers and fabrication method thereof
WO2010110852A1 (en) * 2009-03-23 2010-09-30 Cabot Corporation A particle containing a hydrophobic region and a hydrophilic region and methods to make same
US9062144B2 (en) 2009-04-03 2015-06-23 Bridgestone Corporation Hairy polymeric nanoparticles with first and second shell block polymer arms
US8703877B2 (en) * 2009-11-11 2014-04-22 3M Innovative Properties Company Polymeric compositions and method of making and articles thereof
AU2010339809B2 (en) 2009-12-17 2016-05-05 The Washington University Antithrombotic nanoparticle
US9808500B2 (en) 2009-12-17 2017-11-07 Washington University Antithrombotic nanoparticle
US9115222B2 (en) 2009-12-29 2015-08-25 Bridgestone Corporation Well defined, highly crosslinked nanoparticles and method for making same
US20110172364A1 (en) * 2009-12-29 2011-07-14 Chen Yaohong Charged Nanoparticles And Method Of Controlling Charge
US8288001B1 (en) 2010-02-16 2012-10-16 Sandia Corporation Method of making monodisperse nanoparticles
AU2011220748B2 (en) 2010-02-24 2015-11-05 Relypsa, Inc. Amine polymers for use as bile acid sequestrants
US8765098B2 (en) 2010-03-30 2014-07-01 International Business Machines Corporation Star polymers, methods of preparation thereof, and uses thereof
US9498439B2 (en) 2010-04-15 2016-11-22 Washington University Prodrug compositions, prodrug nanoparticles, and methods of use thereof
US20130210156A1 (en) * 2010-05-14 2013-08-15 Karen L. Wooley Uniform, Functionalized, Cross-Linked Nanostructures for Monitoring pH
CN103002921A (zh) 2010-05-14 2013-03-27 马林克罗特有限公司 用于联合的光学成像和治疗的功能性交联纳米结构
EP2637707A4 (en) 2010-11-09 2014-10-01 Kensey Nash Corp ADHESIVES AND METHOD OF USE FOR HERNIEREPARATUR
WO2012068476A2 (en) * 2010-11-18 2012-05-24 University Of South Florida Poly(vinyl benzoate) nanoparticles for molecular delivery
EP2648764A4 (en) * 2010-12-07 2015-03-25 Univ Western Australia MULTIFUNCTION NANOPARTICLES
US9498533B2 (en) 2011-04-04 2016-11-22 Board Of Regents Of The University Of Nebraska Drug delivery compositions and methods
EP2524690A1 (en) * 2011-05-17 2012-11-21 ETH Zurich Method for making customised nanoparticles, nanoparticles and use thereof
US8487017B2 (en) 2011-06-27 2013-07-16 Covidien Lp Biodegradable materials for orthopedic devices based on polymer stereocomplexes
MX347260B (es) * 2011-08-10 2017-04-20 Procter & Gamble Encapsulados.
WO2013041975A2 (en) 2011-08-23 2013-03-28 Vive Crop Protection Inc. Pyrethroid formulations
US20130071482A1 (en) * 2011-09-20 2013-03-21 The University Of Kentucky Research Foundation Block copolymer cross-linked nanoassemblies as modular delivery vehicles
EP2754694A4 (en) * 2011-12-09 2015-05-06 Dainippon Ink & Chemicals FILMOGENIC AUXILIARY, AQUEOUS RESIN COMPOSITION AND SURFACE TREATMENT AGENT OF A STEEL SHEET CONTAINING THE SAME
JP6062454B2 (ja) 2011-12-22 2017-01-18 ヴァイヴ クロップ プロテクション インコーポレイテッドＶｉｖｅ Ｃｒｏｐ Ｐｒｏｔｅｃｔｉｏｎ Ｉｎｃ． ストロビルリン配合物
KR101430697B1 (ko) 2011-12-26 2014-08-18 코오롱인더스트리 주식회사 전기 영동 입자, 전기 영동 입자의 제조 방법, 및 전기 영동 디스플레이 장치
US9428604B1 (en) 2011-12-30 2016-08-30 Bridgestone Corporation Nanoparticle fillers and methods of mixing into elastomers
WO2013138494A1 (en) 2012-03-13 2013-09-19 California Institute Of Technology Periodic nanostructures from self assembled wedge-type block-copolymers
US9382387B2 (en) 2012-03-13 2016-07-05 California Institute Of Technology Rapid self-assembly of block copolymers to photonic crystals
US9127113B2 (en) * 2012-05-16 2015-09-08 Rohm And Haas Electronic Materials Llc Polystyrene-polyacrylate block copolymers, methods of manufacture thereof and articles comprising the same
CA2914556C (en) 2012-06-11 2020-08-18 Vive Crop Protection Inc. Herbicide formulations
US9453943B2 (en) 2012-06-28 2016-09-27 California Institute Of Technology Photonic structures from self assembly of brush block copolymers and polymer blends
KR101422918B1 (ko) * 2012-09-05 2014-07-23 삼성전기주식회사 초소수성 멤브레인 및 이의 제조방법
BR112015007749A2 (pt) 2012-10-08 2017-07-04 Relypsa Inc métodos para tratamento de hipertensão , de hipercaliemia , e de doença renal crônica.
US10226744B2 (en) 2012-10-19 2019-03-12 Danisco Us Inc Stabilization of biomimetic membranes
US9392786B2 (en) 2013-02-05 2016-07-19 Vive Crop Protection, Inc. Mectin and milbemycin polyelectrolyte nanoparticle formulations
JP2016517435A (ja) 2013-03-15 2016-06-16 カラ ファーマシューティカルズ インコーポレイテッド メロペネム誘導体及びその使用
US20150375915A1 (en) * 2013-04-18 2015-12-31 Empire Technology Development Llc Thermostatic packaging materials
US10202479B2 (en) 2013-06-07 2019-02-12 Regents Of The University Of Minnesota Poly(cyclohexylethylene)-polyacrylate block copolymers, methods of manufacture thereof and articles comprising the same
US9283281B2 (en) * 2013-07-12 2016-03-15 University Of South Carolina Preparation of triple responsive nanogel system and its application
WO2015172153A1 (en) 2014-05-09 2015-11-12 Yale University Topical formulation of hyperbranched polyglycerol-coated particles thereof
US11918695B2 (en) * 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
EP4299058A3 (en) * 2014-06-24 2024-03-27 The Trustees of Princeton University Process for encapsulating soluble biologics, therapeutics, and imaging agents
US9782727B2 (en) 2014-07-14 2017-10-10 International Business Machines Corporation Filtration membranes with functionalized star polymers
JP2016052613A (ja) * 2014-09-02 2016-04-14 国立大学法人 千葉大学 コアシェル粒子
CA2959660A1 (en) 2014-09-03 2016-03-10 Genesegues, Inc. Therapeutic nanoparticles and related compositions, methods, and systems
US20170224849A1 (en) * 2014-10-14 2017-08-10 President And Fellows Of Harvard College Microcapsules and uses thereof
US9533051B2 (en) * 2014-12-03 2017-01-03 University Of South Florida Menthol-based nanoparticles for drug delivery
US10005042B2 (en) 2015-02-16 2018-06-26 International Business Machines Corporation Thin film composite forward osmosis membranes with performance enhancing layers
US9931598B2 (en) * 2015-02-16 2018-04-03 International Business Machines Corporation Anti-fouling coatings with star polymers for filtration membranes
US10153513B2 (en) 2015-03-09 2018-12-11 California Institute Of Technology Triblock brush block copolymers
EP3296358A4 (en) * 2015-05-11 2018-12-19 National University Corporation Nagoya University Non-covalent bonding soft elastomer and production process therefor
DE102015212611A1 (de) * 2015-07-06 2017-01-12 Henkel Ag & Co. Kgaa Stern-Block-Kamm-Polymere als bioaktive Trägermatrices für die wirkstofffreisetzende semipermanente Beschichtung von Oberflächen
AU2016378743A1 (en) * 2015-12-22 2018-08-02 The Trustees Of Princeton University Process for encapsulating soluble biologics, therapeutics, and imaging agents
KR101913146B1 (ko) 2016-06-16 2018-11-01 주식회사 엘지화학 양친성 트리블록 고분자
KR101999947B1 (ko) 2016-06-16 2019-07-15 주식회사 엘지화학 양친성 고분자
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
AT519180B1 (de) * 2016-10-14 2018-12-15 Feuerer Josef Mal- und Zeichen-Board
US11053356B2 (en) 2017-03-07 2021-07-06 California Institute Of Technology Control of polymer architectures by living ring-opening metathesis copolymerization
EP3672411A4 (en) 2017-08-25 2021-05-19 Vive Crop Protection Inc. MULTI-COMPONENT, SOIL APPLICABLE PESTICIDAL COMPOSITIONS
WO2019055539A1 (en) 2017-09-12 2019-03-21 Prudhomme Robert K CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME
AU2019284481B2 (en) 2018-06-13 2022-07-14 Abbott Diabetes Care Inc. Temperature-insensitive membrane materials and analyte sensors containing the same
US11731099B2 (en) 2018-07-20 2023-08-22 The Trustees Of Princeton University Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
US20230013324A1 (en) * 2020-02-11 2023-01-19 University Of Florida Research Foundation Compositions including dichotomous composite particles, article including the composition, and structures having superhydrophobic, superoleophobic, or omniphobic surfaces
CN112656763B (zh) * 2020-12-29 2022-07-15 吉林大学 一种基于剪切力响应的载药纳米胶束的制备方法
CN113502690B (zh) * 2021-06-25 2022-08-19 浙江纳美新材料股份有限公司 一种用于食品包装纸染色的水性色浆

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU425620B2 (en) 1967-01-23 1972-06-29 Ici Australia Limited Core-sheel graft copolymers with ion exchange resin shell
AU422536B2 (en) 1968-01-24 1972-03-21 Imperial Chemical Industries Of Australia And New Zealand Limited Ion exchange resins
CH594444A5 (US06491903-20021210-C00024.png) 1972-12-04 1978-01-13 Gerd Birrenbach
DE2732929A1 (de) 1977-07-21 1979-02-01 Bayer Ag Polyaether, verfahren zu ihrer herstellung sowie ihre verwendung als lipidabsorptionshemmer
US4329332A (en) 1978-07-19 1982-05-11 Patrick Couvreur Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them
DE2850058A1 (de) 1978-11-18 1980-05-29 Bayer Ag Polyaether-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4252793A (en) 1979-06-18 1981-02-24 American Lecithin Company Injectable lecithin preparation
US4359478A (en) 1981-07-15 1982-11-16 Basf Wyandotte Corporation Hypocholesterolaemic agents
IT1174495B (it) 1984-02-17 1987-07-01 Nuovo Consoricio Sanitario Nat Composti ad attivita'ipolipemizzante
JPS60195455A (ja) * 1984-03-19 1985-10-03 Toray Ind Inc 血液処理剤
US4649048A (en) 1984-05-11 1987-03-10 Bristol-Myers Company Novel bile sequestrant resin
US4600578A (en) 1984-05-11 1986-07-15 Bristol-Myers Company Method of inhibiting diarrhea
US4604430A (en) 1984-05-11 1986-08-05 Bristol-Myers Company Novel bile sequestrant resin
US5597810A (en) 1984-12-27 1997-01-28 Hoffman; Allan S. Method for reducing absorption of undesired lipids in the gastrointestinal tract
US4593073A (en) 1985-04-23 1986-06-03 The Royal Institution For The Advancement Of Learing (Mcgill Univ.) Polymer resins with amino acid containing pendants for sorption of bile pigments and bile acids
US4681915A (en) * 1985-12-20 1987-07-21 General Electric Company Impact modified polyphenylene ether-polyamide compositions
US5250294A (en) 1986-05-15 1993-10-05 Emory University Improved perfusion medium for transplantation of organs
FR2604903B1 (fr) 1986-10-08 1989-01-13 Sopar Sa Nv Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
DE3743142A1 (de) 1987-12-18 1989-06-29 Wacker Chemie Gmbh Verfahren zur emulsionspolymerisation von pfropfcopolymeren
US4851318A (en) * 1988-06-24 1989-07-25 Xerox Corporation Process for encapsulated toner compositions with oligomeric surfactant emulsifiers
JPH0277266A (ja) 1988-09-14 1990-03-16 Kuraray Co Ltd 吸着剤
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5260272A (en) 1991-03-29 1993-11-09 University Of South Alabama Polyanionic polyamino acid inhibitors of mineral deposition and their synthesis
CA2042870C (en) 1991-05-17 1996-11-26 Leon Edward St. Pierre Metal ion coordinated polyamine resins for the lowering of blood cholesterol
JPH05178916A (ja) 1991-12-30 1993-07-20 Kao Corp 自己架橋性重合体エマルションの製造方法
CA2087125A1 (en) 1992-01-23 1993-07-24 Mridula Nair Chemically fixed micelles
US5384333A (en) 1992-03-17 1995-01-24 University Of Miami Biodegradable injectable drug delivery polymer
WO1993022427A1 (en) 1992-04-24 1993-11-11 Somatix Therapy Corporation Method of culturing viable cells and method of regulating the level of a compound in a body fluid
ES2110543T3 (es) * 1992-07-22 1998-02-16 Hoechst Ag Derivados de poli(vinil-aminas) que tienen centros hidrofilos, procedimiento para su preparacion asi como la utilizacion de los compuestos como medicamentos, vehiculos de sustancias activas e ingredientes auxiliares para alimentos.
ATE146193T1 (de) 1992-07-22 1996-12-15 Hoechst Ag Vernetzte, stickstoffhaltige vinylcopolymere, verfahren zu ihrer herstellung sowie die verwendung dieser verbindungen
PL310072A1 (en) * 1993-01-11 1995-11-27 Abacol Ltd Small-diameter microcapsules, method of making them and their applications
AU3462193A (en) * 1993-02-15 1994-08-29 Shield Research Limited Polyalkylcyanoacrylate nanocapsules
US5498421A (en) * 1993-02-22 1996-03-12 Vivorx Pharmaceuticals, Inc. Composition useful for in vivo delivery of biologics and methods employing same
EP0689465A1 (en) 1993-03-18 1996-01-03 Cedars-Sinai Medical Center Drug incorporating and releasing polymeric coating for bioprosthesis
US5414068A (en) * 1994-01-24 1995-05-09 Rohm And Haas Company Crosslinked anion exchange particles and method for producing the particles
US5585108A (en) 1994-12-30 1996-12-17 Nanosystems L.L.C. Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays
US5712346A (en) 1995-02-14 1998-01-27 Avery Dennison Corporation Acrylic emulsion coatings
DE59609259D1 (de) * 1995-11-29 2002-07-04 Vantico Ag Core/Shell-Partikel und diese enthaltende härtbare Epoxidharzzusammensetzungen
AU3585397A (en) * 1996-06-27 1998-01-14 G.D. Searle & Co. Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011703A1 (en) * 1997-08-29 1999-03-11 Biotech Australia Pty. Limited Cross-linked particles

Also Published As

Publication number Publication date
EP0907666A1 (en) 1999-04-14
CA2258744A1 (en) 1997-12-31
JP2001508762A (ja) 2001-07-03
WO1997049736A3 (en) 1998-02-05
US6491903B1 (en) 2002-12-10
WO1997049387A1 (en) 1997-12-31
EP0910351A1 (en) 1999-04-28
US6383500B1 (en) 2002-05-07
JP2000514791A (ja) 2000-11-07
AU3649697A (en) 1998-01-14
CA2258851A1 (en) 1997-12-31
WO1997049736A2 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
AU3585397A (en) Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
AU2990597A (en) Histone deacetylases, and uses related thereto
AU4739297A (en) Halogenated acrylates and polymers derived therefrom
AU2651097A (en) Cross-linked solid polyelectrolyte and use thereof
AU5611798A (en) Packaging and disposal system
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU2683797A (en) Agent vectoring
AU2826797A (en) Client-server application development and deployment system and methods
AU7111496A (en) Information aggregation and synthesization system
AU3331995A (en) Multichromic polymers
AU4443096A (en) Polymers containing macromonomer mixtures
AU3641897A (en) Protected functionalized heterotelechelic polymers and processes for preparing the same
AU4378897A (en) Modified oligosaccharides
AU7223998A (en) Polymers and their preparation
AU2979497A (en) Multilayer-coated powder
AU1819595A (en) Aromatic polymers
AU6865998A (en) Fixative polymers
AU3882697A (en) Polymer devolatilization
AU3432397A (en) An alkylation catalyst and the application thereof
AU6927498A (en) Polymeric films and packages produced therefrom
AU3596897A (en) Sterilant degrading polymeric material
AU3719899A (en) Polymers and their uses
AU4556397A (en) Nonflammable mouldable material based on polyphenylene esters and vinyl aromatic polymers
AU4440396A (en) Improved polymer powder stability
AU4636396A (en) Antiglucocorticoid medicament